1. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial;Palmu;Lancet,2012
2. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study;Prymula;Lancet,2006
3. Tregnaghi MW, Sáez-Llorens X, López P, et al. Evaluating the efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiDCV) against community-acquired pneumonia in Latin America. ESPID 2011; June 7–11, 2011; The Hague, Netherlands, abstr 1411.
4. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group;Black;Pediatr Infect Dis J,2000
5. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial;O'Brien;Lancet,2003